Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
6.97
+0.02 (0.29%)
At close: Nov 3, 2026, 4:00 PM EST
6.75
-0.22 (-3.16%)
After-hours: Nov 3, 2026, 4:10 PM EST
Precision BioSciences Employees
Precision BioSciences had 67 employees as of June 30, 2026. The number of employees decreased by 35 or 34.31% compared to the same quarter last year. That makes Precision BioSciences the 33,664th largest employer in the world and 4,443rd in the United States.
Employees
67
Change (1Y)
-35
Growth (1Y)
-34.31%
Revenue / Employee
$672,269
Profits / Employee
-$575,313
Market Cap
192.38M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 67 | -35 | -34.31% |
| Mar 31, 2026 | 66 | -41 | -38.32% |
| Dec 31, 2025 | 68 | -40 | -37.04% |
| Sep 30, 2025 | 67 | -41 | -37.96% |
| Jun 30, 2025 | 102 | -8 | -7.27% |
| Mar 31, 2025 | 107 | -2 | -1.83% |
| Dec 31, 2024 | 108 | -1 | -0.92% |
| Sep 30, 2024 | 108 | -7 | -6.09% |
| Jun 30, 2024 | 110 | -82 | -42.71% |
| Mar 31, 2024 | 109 | -88 | -44.67% |
| Dec 31, 2023 | 109 | -89 | -44.95% |
| Sep 30, 2023 | 115 | -79 | -40.72% |
| Jun 30, 2023 | 192 | 0 | - |
| Mar 31, 2023 | 197 | 7 | 3.68% |
| Dec 31, 2022 | 198 | 0 | - |
| Sep 30, 2022 | 194 | -32 | -14.16% |
| Jun 30, 2022 | 192 | -44 | -18.64% |
| Mar 31, 2022 | 190 | -47 | -19.83% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| ProQR Therapeutics | 187 |
| Artiva Biotherapeutics | 115 |
| Zentalis Pharmaceuticals | 106 |
| Cartesian Therapeutics | 75 |
| Compugen | 75 |
| Upstream Bio | 75 |
| Alpha Cognition | 71 |
DTIL News
- 7 hours ago - Precision BioSciences Earnings release: Q3 2026 - Filings
- 7 hours ago - Precision BioSciences Quarterly report: Q3 2026 - Filings
- 9 hours ago - Precision BioSciences reports Q3 EPS (28c), consensus (85c) - TheFly
- 9 hours ago - Precision BioSciences Reports Third Quarter 2026 Financial Results and Provides Business Update - Business Wire
- 5 days ago - Precision BioSciences to Report Third Quarter 2026 Financial Results on November 3, 2026 - Business Wire
- 26 days ago - Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting 2026 - Business Wire
- 6 weeks ago - Precision BioSciences Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 2 months ago - BioSciences doses first patient in Phase 1/2 FUNCTION-DMD clinical trial - TheFly